Published in TB and Outbreaks Week, April 11th, 2006
The independent laboratory found that Microbix's technology results in more than a 2-fold increase in the amount of human influenza virus produced through conventional industry methods. More experiments are scheduled, and the company expects to announce final results in the near future.
Once this phase is completed, the study will focus on the application of the technology to avian flu virus, which should be completed this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week